The Improve AD Trial
Dr. Ezra Schwartz (@ezraschwartz10) interviews Dr. Firas Mussa and Mr. Jake Howitt to discuss the IMPROVE-AD Trial, a landmark, multi-institutional study investigating treatment strategies for uncompl...
6 Maj 202540min
JVS CIT Editorials and Abstracts - April 2025
In this episode, we spotlight editorials and abstracts from the Journal of Vascular Surgery Cases, Innovations, and Techniques (JVS-CIT). Editorials and Abstracts are read by Authors as well as member...
21 Apr 202523min
JVS Author Spotlight - Fereydooni and Satam
Audible Bleeding editor Wen (@WenKawaji) is joined by first year vascular fellow Eva (@urrechisme), JVS editor Dr. Forbes (@TL_Forbes), to discuss some of our favorite articles in the JVS family of jo...
6 Apr 202520min
Fellowship Series - 6 Months In
In this episode we catch up with first-year fellows Imani, Yasong, Wen, and Seth as they recap the first 6 months of training and the transition from general surgery to vascular surgery. They recount ...
23 Mars 202549min
JVS Author Spotlight - Gaffey, Hamouda, and Erben
Audible Bleeding editor Wen (@WenKawaji) is joined by first year vascular fellow Eva (@urrechisme), second year vascular fellow Java (@JabbariMD), JVS editor Dr. Forbes (@TL_Forbes), and JVS-VS associ...
9 Mars 202548min
JVS CIT Editorials and Abstracts - February 2025
In this episode, we spotlight editorials and abstracts from the Journal of Vascular Surgery Cases, Innovations, and Techniques (JVS-CIT). Editorials and Abstracts are read by Authors as well as member...
25 Feb 202540min
LifeBTK Trial: Drug-Eluting Resorbable Scaffold versus Angioplasty for Infrapopliteal Artery Disease
In this episode of Audible Bleeding, Jamila, Anh, and Naveed discuss the LifeBTK Trial with Principal Investigator Dr. Brian DeRubertis, where we discuss the new Abbott Esprit everolimus-eluting resor...
11 Feb 202547min
JVS Author Spotlight - Roy, Csore, and Rahimi
Audible Bleeding editor Wen (@WenKawaji) is joined by 3rd year medical student Nishi (@Nishi_Vootukuru), JVS editor Dr. Forbes (@TL_Forbes), and JVS-CIT associate editor Dr. Jimenez to discuss some of...
2 Feb 202533min
